Grants Search Results

This grant is to purchase a Fluorescence Upgrade to Nanozoomer HT Scanner- Digital Imaging For Pediatric Oncology.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant helps provide necessary resources at this institution to ensure that more kids can be treated on clinical trials, their best hope for a cure.

This grant funds a staff person to manage the Long-Term Survivor Clinic, providing comprehensive care including the enrollment of patients in long-term research studies.

This grant funds the development of a comprehensive long-term follow-up program to monitor and treat secondary cancers and the many other health issues that young cancer patients face as they enter into adulthood.

Funding from the St. Baldrick's Foundation has taken two very small programs at UIC and Rush Medical Centers, merged them and brought Stroger Medical Center into the fold to forge a single entity for purposes of participation in Children's Oncology Group clinical trials, significantly increasing clinical trial participation. This grant provides personnel vital to this unique effort.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant helps provide staffing to ensure that more kids can be treated on clinical trials, their best hope for a cure, at this institution.

This grant is to support bioinformatics specialists who will create databases to analyze complex data. The ALL Committee will then be one step closer to achieving the goal of maximizing cure while minimizing toxicity for childhood leukemia. Funds administered by Nationwide Children's Hospital.

This grant is to develop a limited, multi-institutional research consortium aimed at effectively conducting therapeutic trials in cancer survivors. Funds administered by the University of Minnesota - Twin Cities.

This grant is to develop new therapeutic clinical trials for children with neuroblastoma and medulloblastoma. Funds originally administered by the University of Vermont and State Agricultural College and transferred to the Van Andel Research Institute. Learn More at www.nmtrc.org.

This grant helps provide necessary resources at this institution to ensure that more kids can be treated on clinical trials, their best hope for a cure.

This grant helps provide necessary resources at this institution to ensure that more kids can be treated on clinical trials, their best hope for a cure.

Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, and relapsed ALL is the most common cause of death in children with cancer. The goal of this research is to use technical breakthroughs in human genomics to discover the underlying biological pathways involved in relapse. These discoveries will also potentially inform future treatment studies. Dr. Hogan was a St. Baldrick's Fellow and now has a faculty position.

Children with brain tumors and acute lymphoblastic leukemia are at risk for developing learning and memory problems as a result of their disease and treatments. Since we currently cannot prevent this, difficulties are addressed after they appear, with only modest improvements. A computerized cognitive training program, easily used at home with little oversight from parents or professionals, has been tested in survivors of pediatric cancer with memory problems; this project tests it on children during treatment, before the problems develop. If effective, the program has considerable potential to improve the quality of life in pediatric cancer patients.

With every new pediatric cancer diagnoses, a family is given the most unexpected and stressful news of their lives. This kind of stress makes people more susceptible to post-traumatic stress and depression, and also diminishes the immune system, allowing the body to become sick more often. This project examines the level of chronic stress felt by the parents of children and the factors involved. It is vital that we work to improve the outcomes for both patients and their families.

Neuroblastoma is a cancer that develops in the nervous tissue and most cases occur in children younger than two years old. For patients with high-risk disease overall survival remains poor, thus there is a tremendous need to develop new treatments. This research will allow us to improve the clinical development of a new drug, MLN 8237, which has shown promise in early pediatric clinical trials, and could improve survival in this devastating disease and provide additional targets for therapeutic intervention.